Newborn Screening Market

Industry Overview

The Global Newborn Screening Market is expected to grow at an annual growth rate of 7.8 percent from USD 0.85 billion in 2023 to USD 1.8 billion in 2030. The rising prevalence of newborn disorders, as well as favorable reimbursement policies, are driving growth in this market. The availability of refurbished goods, on the other hand, is expected to limit the market's growth during the forecast period.

The increased incidence of newborn metabolic, hormonal, and genetic disorders, as well as favourable government policies, are driving the growth of newborn screening.

Furthermore, healthcare providers' decision-making is hampered by a shortage of evidence on the long-term effects of new diseases and a scarcity of follow-up information for screened conditions. As a result, in the newborn screening industry, there is a need to standardise valuation techniques for paediatric health states.

Market Segmentation

By Test

•    Dry blood spot tests
•    Hearing screening tests
•    CCHD screening tests

Due to the widespread acceptance of dry blood spot tests for screening disorders, the dry blood spot tests segment accounted for the largest share of the newborn screening market.

By Technology

•    Immune assays & enzymatic assays
•    Tandem mass spectrometry
•    Molecular assays
•    Hearing screening technologies
•    Pulse oximetry
•    Other Technologies (Flouroscence, gel electrophoresis and etc.)

Pulse oximetry is expected to dominate the market due to the widespread use of this device in the medical industry as it is used regularly to diagnose disorders in newborn babies.

Regional Outlook 

•   North America
•   Europe
•   Asia Pacific
•   Central & South America
•   Middle East & Africa

During the forecast era, the market in the Asia Pacific is expected to expand at the fastest pace. The presence of a large pool of newborns, the rising prevalence of newborn disorders, the growing understanding of early disease diagnosis, and the attention of key players in this area are all driving growth in this market.

Market Trends

Consumables accounted for the majority of the newborn screening industry in 2019. The relentless demand for consumables in newborn screening accounts for this market segment's large share. The rising prevalence of newborn diseases and the rate of newborn screening around the world are two major factors supporting the growth of consumables.

In the coming years, the size of the newborn screening test market will reach new heights. In the global economy, the newborn screening market share will rapidly expand. By the end of 2025, the newborn screening business sector will have reached its peak and will make a significant contribution to the global economy.

Global Newborn Screening Market Report Coverage

Market Drivers

The global newborn screening market has reached its maximum potential and is steadily expanding in scale. The number of newborn babies is growing every day, necessitating massive growth in the newborn screening market. New-born screening market growth would be aided by technological advances in the development of new-born screening systems. Several countries' governments are funding various newborn screening services and taking a variety of steps to raise public awareness about newborn screening and the benefits associated with it. Various non-profit and government organisations are working to improve the welfare of both the baby and the mother. The government is also loosening controls on the production and selling of newborn screening devices, which would enable manufacturers to create more diverse systems. Campaigns to raise disease awareness will evolve the potential of the internet.

Opportunities

The market for newborn screening systems is expected to expand rapidly in the coming years, thanks to the rising demand for newborn screening systems. Several technical advances in the newborn screening method would act as a demand booster for the growth of the newborn screening market. The growing population of newborn children would significantly contribute to the growth of the newborn screening market share. Governments in various countries are also raising awareness about newborn screening procedures and taking steps to help the newborn screening industry. In the forecast era, both of these opportunities will drive the newborn screening market to greater heights.

Challenges

The newborn screening market is growing at a rapid pace, but it also faces some challenges. The lack of adequate healthcare facilities and infrastructure is posing a greater obstacle to the growth of the newborn screening industry. Newborn screening tests are not always accurate, resulting in product unreliability. There are very few skilled professionals who can properly handle the screening procedure, which creates a roadblock in the newborn screening market's growth direction.

COVID-19 Impact on the Global Newborn Screening Market

COVID-19 has had a minimal effect on the newborn screening market, despite the fact that it has affected many segments of the medical devices and diagnostics industry. Legislation in key markets has also stressed the importance of newborn screening, with strict laws in place to monitor newborn health and protect babies from diseases like COVID-19. Many screening laboratories and government agencies educate parents about their children's health.

COVID-19, on the other hand, disrupted the production and distribution activities of major market players such as Natus (US), PerkinElmer (US), and Masimo (US) in Q2 2020. However, operations resumed in Q3 as countries lifted their embargoes and allowed the transport of medical supplies.

Market Key Players

•    PerkinElmer
•    Demant A/S
•    Natus Medical
•    Bio-Rad Laboratories
•    Danaher Corporation
•    Medtronic 
•    Chromsystems Instruments & Chemicals GmbH 
•    Trivitron Healthcare 
•    Baebies
•    Recipe Chemicals+Instruments

Recent Developments

•    PerkinElmer (US) received CE-IVD approval in September 2020 for the EONIS screening assay, which is used to screen newborns for SMA (spinal muscular atrophy), SCID (severe combined immunodeficiency), and XLA (X-linked agammaglobulinemia).
•    The GSP Neonatal Creatine Kinase –MM (CK-MM) kit was approved by the US FDA in December 2019 for screening newborns with Duchenne muscular dystrophy (DMD)
•    At the 64th International Congress of Hearing Aid Acousticians in Nuremberg, Germany, in October 2019, Demant A/S (Denmark) launched its easy screen BERAphone, a hearing screening system.

The Newborn Screening Market report offers a comprehensive market segmentation analysis along with an estimation for the forecast period 2025–2030.

Segments Covered in the Report

• By Test
  • Robotic Systems
  • Services
• By Technology
  • Inspection and Measurement
  • Object Reconstruction
  • Projection and Navigation
  • Reporting and Virtualization
  • Others

Region Covered in the Report

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • South Korea
  • Rest of Asia-Pacific
• Rest of the World (RoW)
  • Brazil
  • Saudi Arabia
  • South Africa
  • U.A.E.
  • Other Countries

Source: VynZ Research

Source: VynZ Research

1.    Research Overview 

        1.1.    The Report Offers
        1.2.    Market Coverage
                1.2.1.    By Test
                1.2.2.    By Technology
        1.3.    Research Phases
        1.4.    Limitations
        1.5.    Research Methodology
                1.5.1.    Data Sources
                        1.5.1.1.    Primary Research
                        1.5.1.2.    Secondary Research
                1.5.2.    Methodology
                        1.5.2.1.    Data Exploration
                        1.5.2.2.    Forecast Parameters
                        1.5.2.3.    Data Validation
                        1.5.2.4.    Assumptions
                1.5.3.    Study Period & Data Reporting Unit

2.    Executive Summary

3.    Industry Overview

        3.1.    Industry Dynamics
                3.1.1.    Market Growth Drivers
                3.1.2.    Market Restraints
                3.1.3.    Key Market Trends
                3.1.4.    Major Opportunities
        3.2.    Industry Ecosystem
                3.2.1.    Porter’s Five Forces Analysis
                3.2.2.    Recent Development Analysis
                3.2.3.    Value Chain Analysis
        3.3.    Competitive Insight
                3.3.1.    Competitive Position of Industry Players
                3.3.2.    Market Attractive Analysis

4.    Global Market Estimate and Forecast

        4.1.    Global Market Overview
        4.2.    Global Market Estimate and Forecast to 2030

5.    Market Segmentation Estimate and Forecast

        5.1.    By Test
                5.1.1.    Dry blood spot tests
                        5.1.1.1.    Market Definition
                        5.1.1.2.    Market Estimation and Forecast to 2030
                5.1.2.    Hearing screening tests
                        5.1.2.1.    Market Definition
                        5.1.2.2.    Market Estimation and Forecast to 2030
                5.1.3.    CCHD screening tests
                        5.1.3.1.    Market Definition
                        5.1.3.2.    Market Estimation and Forecast to 2030

        5.2.    By Technology
                5.2.1.    Immune assays & enzymatic assays
                        5.2.1.1.    Market Definition
                        5.2.1.2.    Market Estimation and Forecast to 2030
                5.2.2.    Tandem mass spectrometry
                        5.2.2.1.    Market Definition
                        5.2.2.2.    Market Estimation and Forecast to 2030
                5.2.3.    Molecular assays
                        5.2.3.1.    Market Definition
                        5.2.3.2.    Market Estimation and Forecast to 2030
                5.2.4.    Hearing screening technologies
                        5.2.4.1.    Market Definition
                        5.2.4.2.    Market Estimation and Forecast to 2030
                5.2.5.    Pulse oximetry
                        5.2.5.1.    Market Definition
                        5.2.5.2.    Market Estimation and Forecast to 2030
5.2.6.    Other Technologies (Flouroscence, gel electrophoresis and etc.)
                        5.2.6.1.    Market Definition
                        5.2.6.2.    Market Estimation and Forecast to 2030

6.    North America Market Estimate and Forecast

        6.1.    By Test 
        6.2.    By Technology
        6.3.    By Country
                6.3.1.    U.S. Market Estimate and Forecast
                6.3.2.    Canada Market Estimate and Forecast
                6.3.3.    Mexico Market Estimate and Forecast

7.    Europe Market Estimate and Forecast

        7.1.    By Test 
        7.2.    By Technology
        7.3.    By Country
                7.3.1.    Germany Market Estimate and Forecast
                7.3.2.    France Market Estimate and Forecast
                7.3.3.    U.K. Market Estimate and Forecast
                7.3.4.    Italy Market Estimate and Forecast
                7.3.5.    Spain Market Estimate and Forecast
                7.3.6.    Russia Market Estimate and Forecast
                7.3.7.    Rest of Europe Market Estimate and Forecast

8.    Asia-Pacific Market Estimate and Forecast

        8.1.    By Test
        8.2.    By Technology
        8.3.    By Country 
                8.3.1.    China Market Estimate and Forecast
                8.3.2.    Japan Market Estimate and Forecast
                8.3.3.    India Market Estimate and Forecast
                8.3.4.    South Korea Market Estimate and Forecast
                8.3.5.    Rest of Asia-Pacific Market Estimate and Forecast

9.    Rest of the World (RoW) Market Estimate and Forecast

        9.1.    By Test
        9.2.    By Technology
        9.3.    By Country
                9.3.1.    Brazil Market Estimate and Forecast
                9.3.2.    Saudi Arabia Market Estimate and Forecast
                9.3.3.    South Africa Market Estimate and Forecast
                9.3.4.    U.A.E. Market Estimate and Forecast
                9.3.5.    Other Countries Market Estimate and Forecast

10.    Company Profiles

        10.1.    PerkinElmer
                10.1.1.    Snapshot
                10.1.2.    Overview
                10.1.3.    Offerings
                10.1.4.    Financial Insight
                10.1.5.    Recent Developments
        10.2.    Demant A/S
                10.2.1.    Snapshot
                10.2.2.    Overview
                10.2.3.    Offerings
                10.2.4.    Financial Insight
                10.2.5.    Recent Developments
        10.3.    Natus Medical
                10.3.1.    Snapshot
                10.3.2.    Overview
                10.3.3.    Offerings
                10.3.4.    Financial Insight
                10.3.5.    Recent Developments
        10.4.    Bio-Rad Laboratories
                10.4.1.    Snapshot
                10.4.2.    Overview
                10.4.3.    Offerings
                10.4.4.    Financial Insight
                10.4.5.    Recent Developments
        10.5.    Danaher Corporation
                10.5.1.    Snapshot
                10.5.2.    Overview
                10.5.3.    Offerings
                10.5.4.    Financial Insight
                10.5.5.    Recent Developments
        10.6.    Medtronic
                10.6.1.    Snapshot
                10.6.2.    Overview
                10.6.3.    Offerings
                10.6.4.    Financial Insight
                10.6.5.    Recent Developments
        10.7.    Chromsystems Instruments & Chemicals GmbH
                10.7.1.    Snapshot
                10.7.2.    Overview
                10.7.3.    Offerings
                10.7.4.    Financial Insight
                10.7.5.    Recent Developments
        10.8.    Trivitron Healthcare
                10.8.1.    Snapshot
                10.8.2.    Overview
                10.8.3.    Offerings
                10.8.4.    Financial Insight
                10.8.5.    Recent Developments
        10.9.    Baebies
                10.9.1.    Snapshot
                10.9.2.    Overview
                10.9.3.    Offerings
                10.9.4.    Financial Insight
                10.9.5.    Recent Developments
        10.10.    Recipe Chemicals+Instruments
                10.10.1.    Snapshot
                10.10.2.    Overview
                10.10.3.    Offerings
                10.10.4.    Financial Insight
                10.10.5.    Recent Developments

11.    Appendix

        11.1.    Exchange Rates
        11.2.    Abbreviations

List of Tables

Table 1 Sources
Table 2 Study Periods
Table 3 Data Reporting Unit
Table 4 Global Newborn Screening Market Size, By Test Type, 2018 - 2023 (USD Billion)
Table 5 Global Newborn Screening Market Size, By Test Type, 2025 - 2030 (USD Billion)
Table 6 Global Newborn Screening Market Size, By Technology Type, 2018 - 2023 (USD Billion)
Table 7 Global Newborn Screening Market Size, By Technology Type, 2025 - 2030 (USD Billion)
Table 8 Global Newborn Screening Market Size, by Region, 2018 - 2023 (USD Billion)
Table 9 Global Newborn Screening Market Size, by Region, 2025 - 2030 (USD Billion)
Table 10 North America Newborn Screening Market Size, By Test Type, 2018 - 2023 (USD Billion)
Table 11 North America Newborn Screening Market Size, By Test Type, 2025 - 2030 (USD Billion)
Table 12 North America Newborn Screening Market Size, By Technology Type, 2018 - 2023 (USD Billion)
Table 13 North America Newborn Screening Market Size, By Technology Type, 2025 - 2030 (USD Billion)
Table 14 North America Newborn Screening Market Size, by Region, 2018 - 2023 (USD Billion)
Table 15 North America Newborn Screening Market Size, by Region, 2025 - 2030 (USD Billion)
Table 16 Europe Newborn Screening Market Size, By Test Type, 2018 - 2023 (USD Billion)
Table 17 Europe Newborn Screening Market Size, By Test Type, 2025 - 2030 (USD Billion)
Table 18 Europe Newborn Screening Market Size, By Technology Type, 2018 - 2023 (USD Billion)
Table 19 Europe Newborn Screening Market Size, By Technology Type, 2025 - 2030 (USD Billion)
Table 20 Europe Newborn Screening Market Size, by Region, 2018 - 2023 (USD Billion)
Table 21 Europe Newborn Screening Market Size, by Region, 2025 - 2030 (USD Billion)
Table 22 Asia-Pacific Newborn Screening Market Size, By Test Type, 2018 - 2023 (USD Billion)
Table 23 Asia-Pacific Newborn Screening Market Size, By Test Type, 2025 - 2030 (USD Billion)
Table 24 Asia-Pacific Newborn Screening Market Size, By Technology Type, 2018 - 2023 (USD Billion)
Table 25 Asia-Pacific Newborn Screening Market Size, By Technology Type, 2025 - 2030 (USD Billion)
Table 26 Asia-Pacific Newborn Screening Market Size, by Region, 2018 - 2023 (USD Billion)
Table 27 Asia-Pacific Newborn Screening Market Size, by Region, 2025 - 2030 (USD Billion)
Table 28 RoW Newborn Screening Market Size, By Test Type, 2018 - 2023 (USD Billion)
Table 29 RoW Newborn Screening Market Size, By Test Type, 2025 - 2030 (USD Billion)
Table 30 RoW Newborn Screening Market Size, By Technology Type, 2018 - 2023 (USD Billion)
Table 31 RoW Newborn Screening Market Size, By Technology Type, 2025 - 2030 (USD Billion)
Table 32 RoW Newborn Screening Market Size, by Region, 2018 - 2023 (USD Billion)
Table 33 RoW Newborn Screening Market Size, by Region, 2025 - 2030 (USD Billion)
Table 34 Snapshot – PerkinElmer
Table 35 Snapshot – Demant A/S
Table 36 Snapshot – Natus Medical
Table 37 Snapshot – Bio-Rad Laboratories
Table 38 Snapshot – Danaher Corporation
Table 39 Snapshot – Medtronic 
Table 40 Snapshot – Chromsystems Instruments & Chemicals GmbH
Table 41 Snapshot – Trivitron Healthcare Airbus
Table 42 Snapshot – Baebies 
Table 43 Snapshot – Recipe Chemicals+Instruments

List of Figures

Figure 1 Market Coverage
Figure 2 Research Phases
Figure 3 Secondary Sources for Different Parameters
Figure 4 Methodology
Figure 5 Data Mining & Exploration
Figure 6 Data Triangulation
Figure 7 Assumptions for Market Estimation and Forecast
Figure 8 Market Synopsis
Figure 9 Global Automotive V2X Market - Growth Drivers and Restraints
Figure 10 Competitive Benchmark
Figure 11 Global Newborn Screening Market Highlight
Figure 12 Global Newborn Screening Market Size, By Test Type, 2018 - 2030 (USD Billion)
Figure 13 Global Newborn Screening Market Size, By Technology Type, 2018 - 2030 (USD Billion)
Figure 14 Global Newborn Screening Market Size, by Region, 2018 - 2030 (USD Billion)
Figure 15 North America Newborn Screening Market Highlight
Figure 16 North America Newborn Screening Market Size, By Test Type, 2018 - 2030 (USD Billion)
Figure 17 North America Newborn Screening Market Size, By Technology Type, 2018 - 2030 (USD Billion)
Figure 18 North America Newborn Screening Market Size, by Region, 2018 - 2030 (USD Billion)
Figure 19 Europe Newborn Screening Market Highlight
Figure 20 Europe Newborn Screening Market Size, By Test Type, 2018 - 2030 (USD Billion)
Figure 21 Europe Newborn Screening Market Size, By Technology Type, 2018 - 2030 (USD Billion)
Figure 22 Europe Newborn Screening Market Size, by Region, 2018 - 2030 (USD Billion)
Figure 23 Asia-Pacific Newborn Screening Market Highlight
Figure 24 Asia-Pacific Newborn Screening Market Size, By Test Type, 2018 - 2030 (USD Billion)
Figure 25 Asia-Pacific Newborn Screening Market Size, By Technology Type, 2018 - 2030 (USD Billion)
Figure 26 Asia-Pacific Newborn Screening Market Size, by Region, 2018 - 2030 (USD Billion)
Figure 27 RoW Newborn Screening Market Highlight
Figure 28 RoW Newborn Screening Market Size, By Test Type, 2018 - 2030 (USD Billion)
Figure 29 RoW Newborn Screening Market Size, By Technology Type, 2018 - 2030 (USD Billion)
Figure 30 RoW Newborn Screening Market Size, by Region, 2018 - 2030 (USD Billion)